BACKGROUND: Clinical inertia, which has been defined as the recognition of a problem
with a patient's management but failing to act, is a concern in type 2 diabetes (T2D) because …

BACKGROUND: In patients with type 2 diabetes (T2D) with poor glycemic control, there is
an unmet need for treatment optimization involving the initiation and/or intensification of …

Purpose The purpose of this study was to determine whether “clinical inertia”—inadequate
intensification of therapy by the provider—could contribute to high A1C levels in patients …

Aims Clinical inertia, the tendency to maintain current treatment strategies despite results
demanding escalation, is thought to substantially contribute to the disconnect between …

Aim The INTEGRA study evaluated whether a specially designed multicomponent health
care intervention improved glycaemic control in subjects with poorly controlled type 2 …

Background The management of hyperglycaemia and associated cardiovascular risk factors
in patients with type 2 diabetes mellitus (T2DM) may reduce diabetes-related complications …

Research has shown that getting to glycemic targets early on leads to better outcomes in
people with type 2 diabetes; yet, there has been no improvement in the attainment of A1C …

The ultimate purpose of diabetes care is achieving the outcomes that patients regard as
important throughout the life course. Despite advances in pharmaceuticals, nutraceuticals …

OBJECTIVE—Management of diabetes is frequently suboptimal in primary care settings,
where providers often fail to intensify therapy when glucose levels are high, a problem …

Background Although clinical trials have shown that proper management of diabetes can
improve outcomes, and treatment guidelines are widespread, glycated hemoglobin (HbA1c) …